Actionable news
All posts from Actionable news
Actionable news in CBMX: CombiMatrix Corporation,

Aytu BioScience Expands MiOXSYS® Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe

ENGLEWOOD, Colo., July 13, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the signing of an exclusive distribution agreement for MiOXSYS® with GryNumber Health – a leading specialty healthcare company serving the fertility market throughout Central and Southeast Europe and Scandinavia.

(PRNewsfoto/Aytu BioScience, Inc.)

Josh Disbrow, Chief Executive Officer of Aytu, commented, "We are very pleased to further expand our worldwide distribution network for MiOXSYS®. GryNumber Health is an ideal partner for Aytu given their footprint in more than 20 countries in Europe and their specific focus on marketing solutions in the fertility field. Our expanding network of distributors for MiOXSYS® continues to demonstrate the significant interest and need for an innovative diagnostic platform that has the potential to benefit the millions of men worldwide dealing with infertility."

Valdemaras Rodzko, Chief Executive Officer of GryNumber Health, stated, "GryNumber Health is establishing itself as a leader in the diagnosis and treatment of male and female infertility throughout Europe and we are very enthusiastic about bringing MiOXSYS® to our many customers. The MiOXSYS® platform is an exciting advancement in male infertility, and we are optimistic about its significant potential in Europe and worldwide. We look forward to a successful partnership with Aytu and helping to further establish MiOXSYS® as an important diagnostic that will be beneficial to the millions of European men challenged by infertility."

Aytu expects to continue to expand its ex-U.S. distribution channel in line with ramping commercial sales in territories where MiOXSYS® is approved while the company pursues regulatory clearance in the U.S. through the FDA's 510(k) pathway.

About Aytu BioScience, Inc.

Aytu BioScience is a commercial-stage specialty life sciences company focused on global commercialization of novel...